Resverlogix Corp. (TSE:RVX – Get Free Report)’s share price hit a new 52-week low during trading on Tuesday. The company traded as low as C$0.07 and last traded at C$0.07, with a volume of 2,850 shares traded. The stock had previously closed at C$0.07.
Resverlogix Stock Down 12.5%
The firm has a fifty day moving average of C$0.09 and a 200 day moving average of C$0.10. The company has a quick ratio of 0.04, a current ratio of 0.04 and a debt-to-equity ratio of -82.47. The stock has a market cap of C$24.10 million, a PE ratio of -1.75 and a beta of -0.36.
About Resverlogix
Founded in 2001, Resverlogix is a Calgary based late-stage biotechnology company, and a world leader in epigenetics, with the goal of developing first-in-class therapies for the benefit of patients with chronic disease. Resverlogix is developing a new class of epigenetic therapies designed to regulate the expression of disease-causing genes. We aim to improve patients’ lives by restoring biological functions – altered by serious illnesses such as cardiovascular disease – back to a healthier state.
Recommended Stories
- Five stocks we like better than Resverlogix
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg){kind=logo}
